Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
---|---|---|---|
USD 671.3 Million | USD 1290.55 Million | 6.9% | 2024 |
FrequentlyAsked Questions
A retrovirus is a single-stranded RNA virus that contains the reverse transcriptase enzyme.
The global retrovirus testing market is expected to grow due to rising prevalence of retroviral infections, growing demand for early disease detection, and advancements in molecular diagnostic techniques.
According to a study, the global retrovirus testing market size was worth around USD 671.3 Million in 2024 and is expected to reach USD 1290.55 Million by 2034.
The global retrovirus testing market is expected to grow at a CAGR of 6.9% during the forecast period.
North America is expected to dominate the retrovirus testing market over the forecast period.
Leading players in the global retrovirus testing market include BGI Genomics, Abbott Diagnostics, Alere Inc, Hybribio Biotech, Roche Diagnostics Ltd, Tellgen Corporation, DiaSorin S.p.A., Dian Diagnostics, bioMerieux SA, Becton, Dickinson & Company, Xilong Scientific., among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed